United States · FDA National Drug Code directory
Bionara ULTRA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85477-710_6cd37233-b8b5-4018-b1e4-07611306a562
- Product NDC
- 85477-710
- Form
- CAPSULE
- Composition / generic term
- Probiotic Dietary Supplement Capsules
- Labeler
- Oncora Pharma, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20260223
- Source listing expiry
- 20271231
Source-listed ingredients
- LACTOBACILLUS ACIDOPHILUS LA 14 — 410 mg/1
- BIFIDOBACTERIUM ANIMALIS LACTIS BL04 — 410 mg/1
- LACTIPLANTIBACILLUS PLANTARUM — 410 mg/1
- LACTICASEIBACILLUS PARACASEI LPC-37 — 410 mg/1
- LESSONIA NIGRESCENS — 25 mg/1
- BETA VULGARIS ROOT FRUCTOOLIGOSACCHARIDES — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE in 1 BOTTLE (85477-710-30) · 85477-710-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →